@article{bhatti_superficial_2012,
	title = {Superficial pyoderma gangrenosum treated with infliximab: a case report},
	volume = {90},
	copyright = {All rights reserved},
	issn = {0011-4162 (Print) 0011-4162 (Linking)},
	url = {https://www.ncbi.nlm.nih.gov/pubmed/23409478},
	abstract = {We report a case of superficial pyoderma gangrenosum (SPG) that was successfully treated with infliximab. A 22-year-old man presented with several polycyclic, purplish red plaques with some crusting and well-defined edges on the bilateral lower extremities. Histology showed superficial and deep mixed inflammatory cell infiltrate with prominent neutrophils and scarring noted as a result of multiple sinus tract formations that were characteristic of SPG. After unsuccessful results with typical treatments (ie, steroids, antibiotics, immunosuppressants), the patient was successfully treated with infliximab.},
	number = {6},
	journal = {Cutis},
	author = {Bhatti, H. and Khalid, N. and Rao, B.},
	month = dec,
	year = {2012},
	keywords = {Adult, Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use, Antibodies, Monoclonal/*therapeutic use, Humans, Infliximab, Male, Pyoderma Gangrenosum/*drug therapy/pathology, Young Adult},
	pages = {297--9},
}

{"_id":"ALEEwkesCzdTPcbpL","bibbaseid":"bhatti-khalid-rao-superficialpyodermagangrenosumtreatedwithinfliximabacasereport-2012","author_short":["Bhatti, H.","Khalid, N.","Rao, B."],"bibdata":{"bibtype":"article","type":"article","title":"Superficial pyoderma gangrenosum treated with infliximab: a case report","volume":"90","copyright":"All rights reserved","issn":"0011-4162 (Print) 0011-4162 (Linking)","url":"https://www.ncbi.nlm.nih.gov/pubmed/23409478","abstract":"We report a case of superficial pyoderma gangrenosum (SPG) that was successfully treated with infliximab. A 22-year-old man presented with several polycyclic, purplish red plaques with some crusting and well-defined edges on the bilateral lower extremities. Histology showed superficial and deep mixed inflammatory cell infiltrate with prominent neutrophils and scarring noted as a result of multiple sinus tract formations that were characteristic of SPG. After unsuccessful results with typical treatments (ie, steroids, antibiotics, immunosuppressants), the patient was successfully treated with infliximab.","number":"6","journal":"Cutis","author":[{"propositions":[],"lastnames":["Bhatti"],"firstnames":["H."],"suffixes":[]},{"propositions":[],"lastnames":["Khalid"],"firstnames":["N."],"suffixes":[]},{"propositions":[],"lastnames":["Rao"],"firstnames":["B."],"suffixes":[]}],"month":"December","year":"2012","keywords":"Adult, Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use, Antibodies, Monoclonal/*therapeutic use, Humans, Infliximab, Male, Pyoderma Gangrenosum/*drug therapy/pathology, Young Adult","pages":"297–9","bibtex":"@article{bhatti_superficial_2012,\n\ttitle = {Superficial pyoderma gangrenosum treated with infliximab: a case report},\n\tvolume = {90},\n\tcopyright = {All rights reserved},\n\tissn = {0011-4162 (Print) 0011-4162 (Linking)},\n\turl = {https://www.ncbi.nlm.nih.gov/pubmed/23409478},\n\tabstract = {We report a case of superficial pyoderma gangrenosum (SPG) that was successfully treated with infliximab. A 22-year-old man presented with several polycyclic, purplish red plaques with some crusting and well-defined edges on the bilateral lower extremities. Histology showed superficial and deep mixed inflammatory cell infiltrate with prominent neutrophils and scarring noted as a result of multiple sinus tract formations that were characteristic of SPG. After unsuccessful results with typical treatments (ie, steroids, antibiotics, immunosuppressants), the patient was successfully treated with infliximab.},\n\tnumber = {6},\n\tjournal = {Cutis},\n\tauthor = {Bhatti, H. and Khalid, N. and Rao, B.},\n\tmonth = dec,\n\tyear = {2012},\n\tkeywords = {Adult, Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use, Antibodies, Monoclonal/*therapeutic use, Humans, Infliximab, Male, Pyoderma Gangrenosum/*drug therapy/pathology, Young Adult},\n\tpages = {297--9},\n}\n\n\n\n","author_short":["Bhatti, H.","Khalid, N.","Rao, B."],"key":"bhatti_superficial_2012","id":"bhatti_superficial_2012","bibbaseid":"bhatti-khalid-rao-superficialpyodermagangrenosumtreatedwithinfliximabacasereport-2012","role":"author","urls":{"Paper":"https://www.ncbi.nlm.nih.gov/pubmed/23409478"},"keyword":["Adult","Anti-Inflammatory Agents","Non-Steroidal/*therapeutic use","Antibodies","Monoclonal/*therapeutic use","Humans","Infliximab","Male","Pyoderma Gangrenosum/*drug therapy/pathology","Young Adult"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/raoresearch","dataSources":["5i38dLwPk6C3jurSL","aGgndugSyribdb2rd","2tgmyzKov4y6MHvQs"],"keywords":["adult","anti-inflammatory agents","non-steroidal/*therapeutic use","antibodies","monoclonal/*therapeutic use","humans","infliximab","male","pyoderma gangrenosum/*drug therapy/pathology","young adult"],"search_terms":["superficial","pyoderma","gangrenosum","treated","infliximab","case","report","bhatti","khalid","rao"],"title":"Superficial pyoderma gangrenosum treated with infliximab: a case report","year":2012}